Eric Humes

Eric Humes serves as Agenus’ Chief Quality Officer (CQO). He heads our Global Quality Control laboratories (QCU), Product Development and Clinical Quality Assurance (QA), and Quality System Risk Management & Process Improvement. Eric’s leadership enables our product development innovation and research to move with speed through a phase appropriate lifecycle focused on building quality into our products and research for the patients we serve. Eric joined Agenus as Vice President, Quality Systems, leading CMC and Clinical Research teams through successful completion of FDA inspections of balstilimab (AGEN2034) in 2021. Prior to joining Agenus, Eric was Executive Director, Quality Assurance at Medpace and Sr. Director QA at ICON Clinical Research, where Eric and his teams provided quality oversight, governance and inspection management in support of nine marketing applications in oncology, cardiovascular, orphan disease and biosimilars. Eric has served as a Director on the Society of Quality Assurance (SQA) Board of Directors, Chairman of SQA Education Committee, and Editorial Board of DIA Peach Initiative. Eric has a B.S. in Biochemistry and Applied Molecular Biology from University of Maryland.